These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Zinc and ifenprodil allosterically inhibit two separate polyamine-sensitive sites at N-methyl-D-aspartate receptor complex. Berger ML, Rebernik P. J Pharmacol Exp Ther; 1999 Jun; 289(3):1584-91. PubMed ID: 10336556 [Abstract] [Full Text] [Related]
29. Polyamine effects on the NMDA receptor in human brain. Subramaniam S, O'Connor MJ, Masukawa LM, McGonigle P. Exp Neurol; 1994 Dec; 130(2):323-30. PubMed ID: 7867761 [Abstract] [Full Text] [Related]
30. Effects of polyamines on the binding of [3H]MK-801 to the N-methyl-D-aspartate receptor: pharmacological evidence for the existence of a polyamine recognition site. Williams K, Romano C, Molinoff PB. Mol Pharmacol; 1989 Oct; 36(4):575-81. PubMed ID: 2554112 [Abstract] [Full Text] [Related]
31. Comparison of the actions of carbamate anticholinesterases on the nicotinic acetylcholine receptor. Sherby SM, Eldefrawi AT, Albuquerque EX, Eldefrawi ME. Mol Pharmacol; 1985 Mar; 27(3):343-8. PubMed ID: 3974572 [Abstract] [Full Text] [Related]
32. Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. Yang XC, Reis DJ. J Pharmacol Exp Ther; 1999 Feb; 288(2):544-9. PubMed ID: 9918557 [Abstract] [Full Text] [Related]
33. Spermine enhances binding to the glycine site associated with the N-methyl-D-aspartate receptor complex. Sacaan AI, Johnson KM. Mol Pharmacol; 1989 Dec; 36(6):836-9. PubMed ID: 2557533 [Abstract] [Full Text] [Related]
35. Potentiation by polyamines of an interaction of noncompetitive antagonists at the N-methyl-D-aspartate receptor ionophore complex with phosphatidylserine. Suzuki T, Ogita K, Yoneda Y. Neurochem Int; 1993 Nov; 23(5):427-40. PubMed ID: 7902748 [Abstract] [Full Text] [Related]
36. Cooperative modulation of [3H]MK-801 binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines. Ransom RW, Stec NL. J Neurochem; 1988 Sep; 51(3):830-6. PubMed ID: 2457653 [Abstract] [Full Text] [Related]
37. Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites. Swanson KL, Aronstam RS, Wonnacott S, Rapoport H, Albuquerque EX. J Pharmacol Exp Ther; 1991 Oct; 259(1):377-86. PubMed ID: 1920124 [Abstract] [Full Text] [Related]
38. Antagonist properties of polyamines and bis(ethyl)polyamines at N-methyl-D-aspartate receptors. Igarashi K, Williams K. J Pharmacol Exp Ther; 1995 Mar; 272(3):1101-9. PubMed ID: 7891322 [Abstract] [Full Text] [Related]
39. Binding of semirigid nicotinic agonists to nicotinic and muscarinic receptors. Spivak CE, Waters JA, Aronstam RS. Mol Pharmacol; 1989 Jul; 36(1):177-84. PubMed ID: 2747625 [Abstract] [Full Text] [Related]
40. Characterization of polyamines having agonist, antagonist, and inverse agonist effects at the polyamine recognition site of the NMDA receptor. Williams K, Dawson VL, Romano C, Dichter MA, Molinoff PB. Neuron; 1990 Aug; 5(2):199-208. PubMed ID: 2166545 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]